Dialysis companies Fresenius and Gambro deny merger talks
This article was originally published in Clinica
Executive Summary
Fresenius has dismissed as "absolute rumour" speculation that it is engaged in merger negotiations with the leading shareholder of its Swedish rival in the dialysis market, Gambro. An article claiming Fresenius and Investor were already having talks appeared in the Swedish daily newspaper, Dagens Industri, two weeks ago.